Epidemiology of varicella and effectiveness of varicella vaccine in Hangzhou, China, 2019

References

• Siu HT, Li JC, Wang M,Liu YM, Yin DP. Varicella epidemiology in China, 2005-2015. Chin J Vaccines Immun. 2019;2:155–59.
   Google Scholar
• Yin D, Song L, Zhang X, Li FJ, Cao LS, Zhang SL, Fan CX, Zhang GM, Zhou YQ, Zheng JS, et al. The investigation on the incidence of varicella in Shandong, Gansu and Hunan provinces in 2007. Chin J Vaccines Immunization. 2009;15(2):119–22.
   Google Scholar
• World Health Organization. Varicella and herpes zoster vaccines: WHO position paper, June 2014-Recommendations. Vaccine. 2016;34(2):198–99. doi:10.1016/j.vaccine.2014.07.068.
   PubMed Web of Science ®Google Scholar
• Hua Z, Han Z, Rong O, Zeng Q, Hu L, Qiu H, Sharma M, Ye M. Spatiotemporal epidemiology of varicella in Chongqing, China, 2014-2018. Int J Environ Res Public Health. 2020;17(2):662. doi:10.3390/ijerph17020662.
   PubMed Web of Science ®Google Scholar
• Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP). Centers for disease control and prevention. MMWR Recomm Rep. 1996 Jul 12;45(RR–11):1–36.
   Google Scholar
• Prevention of varicella: recommendations for use of varicella vaccines in children, including a recommendation for a routine. 2-dose varicella immunization schedule. Pediatrics. 2007 Jul;120(1):221–31. doi: 10.1542/peds.2007-1089
   PubMedGoogle Scholar
• Xu Y, Liu S, Che X, Liu Y, Zhang X, Du J, Zhang X, Wang J, Xu E. Seroepidemiology of varicella in Hangzhou, China in the vaccine era. Hum Vaccin Immunother. 2018;14(10):2464–71. doi:10.1080/21645515.2018.1477909.
   PubMed Web of Science ®Google Scholar
• Varela FH, Pinto LA, Scotta MC. Global impact of varicella vaccination programs. Hum Vaccin Immunother. 2019;15(3):645–57. doi:10.1080/21645515.2018.1546525.
   PubMed Web of Science ®Google Scholar
• Lopez AS, Zhang J, Marin M. Epidemiology of varicella during the 2-dose varicella vaccination program-United States, 2005-2014. Morb Mortal Wkly Rep. 2016;65(34):902–05. doi:10.15585/mmwr.mm6534a4.
   PubMed Web of Science ®Google Scholar
• Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global varicella vaccine effectiveness: a meta-analysis. Pediatrics. 2016;137(3):e20153741–e20153741. doi:10.1542/peds.2015-3741.
   PubMed Web of Science ®Google Scholar
• Liu Y, Xu E, Che X, Wang J, Gu WW, Xu YY, Du J, Zhang XP, Zhang XC. Coverage of two doses of varicella attenuated live vaccine in Hangzhou city of Zhejiang province. Chin J Vaccines Immunization. 2018;24(4):453–56.
   Google Scholar
• Suo L, Lu L, Wang Q, Yang F, Wang X, Pang X, Marin M, Wang C. Varicella outbreak in a highly-vaccinated school population in Beijing, China during the voluntary two-dose era. Vaccine. 2017;35(34):4368–73. doi:10.1016/j.vaccine.2017.06.065.
   PubMed Web of Science ®Google Scholar
• Ma C, Su Q, Hao L. Epidemiology of measles in China, 2017-2018. Chin J Vaccines Immunization. 2020;26(1):5–8.
   Google Scholar
• Riera MM, Bollaerts K, Heininger U, Hens N, Gabutti G, Gil A, Nozad B, Mirinaviciute G, Flem E, Souverain A, et al. Estimation of the burden of varicella in Europe before the introduction of universal childhood immunization. BMC Infect Dis. 2017;17(1):353. doi:10.1186/s12879-017-2445-2.
   PubMedGoogle Scholar
• En TW, Ting AW, Yi HS. Change of epidemiological characteristics and disease burden of varicella due to implementation of mass immunization program in Taiwan from 2000 to 2012[C]. World Academy Sci Eng Tech Int J Med Health Sci. 2017;11(2). https://publications.waset.org/abstracts/56517/change-of-epidemiological-characteristics-and-disease-burden-of-varicella-due-to-implementation-of-mass-immunization-program-in-taiwan-from-2000-to-2012.
   Google Scholar
• Peña Blasco G, Blasco Pérez-Aramendía MJ. A cost-benefit analysis of varicella vaccination in Aragón. Arch Argent Pediatr. 2017;115(5):432–38. doi:10.5546/aap.2017.eng.432.
   PubMed Web of Science ®Google Scholar
• ZJ L, Wang Y, Wang DM. Epidemiological characteristics of varicella in Guizhou, 2013-2017. Mod Prev Med. 2019;46:3101–03.
   Google Scholar
• Plotkin SA, Orenstein WA, Offit PA. Vaccines [M]. 7th ed. Philadelphia (PA): Elsevier; 2018. p. 1145–80.
   Google Scholar
• Sumi A. Role of temperature in reported chickenpox cases in northern European countries: denmark and Finland. BMC Res Notes. 2018;11(1):377. doi:10.1186/s13104-018-3497-0.
   PubMedGoogle Scholar
• Varicella. [accessed 2015 April 15]. https://www.who.int/immunization/diseases/varicella/en/4
   Google Scholar
• Hu Y, Chen Y, Wang Y. Knowledge, attitude and practice of pregnant women towards varicella and their children’s varicella vaccination: evidence from three districts in Zhejiang Province, China. Int J Env Res Public Health. 2017;14(10):pii: E1110.
   Web of Science ®Google Scholar
• Backround paper on varicella vaccines- SAGE working group. [accessed 2014 April]. http://www.who.int/immunization/sage/meetings/2014/april/presentations_background_docs/en/
   Google Scholar
• Smith NTA, Saadia TA, Norowitz KB. Negative IgG varicella zoster virus antibody status: immune responses pre and post re-immunization. Infect Dis. 2018;7:175–81.
   Web of Science ®Google Scholar
• Wang Y, Zhang L, Sun X. Effectiveness and failure rate of the varicella vaccine in an outbreak in Jiangsu, China: a 1:2 matched case-control study. Hum Vaccin Immunother. 2019;10(7):1–7. doi:10.1080/21645515.2019.1690331.
   Google Scholar
• Pan X, Shu M, Ma R, Fang T, Dong H, Sun Y, Xu G. Varicella breakthrough infection and effectiveness of 2-dose varicella vaccine in China. Vaccine. 2018;36(37):5665–70. doi:10.1016/j.vaccine.2018.05.025.
   PubMed Web of Science ®Google Scholar
• Huang W-C, Huang L-M, Chang I-S, Tsai F-Y, Chang L-Y. Varicella breakthrough infection and vaccine effectiveness in Taiwan. Vaccine. 2011;29(15):2756–60. doi:10.1016/j.vaccine.2011.01.092.
   PubMed Web of Science ®Google Scholar
• Thomas CA, Shwe T, Bixler D, Del Rosario M, Grytdal S, Wang C, Haddy LE, Bialek SR. Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students. Pediatric Infect Dis J. 2014;33(11):1164–68. doi:10.1097/INF.0000000000000444.
   PubMed Web of Science ®Google Scholar
• Shapiro ED, Vazquez M, Esposito D, Holabird N, Steinberg SP, Dziura J, LaRussa PS, Gershon AA. Effectiveness of 2 doses of varicella vaccine in children. J Infect Dis. 2011;203(3):312–15. doi:10.1093/infdis/jiq052.
   PubMed Web of Science ®Google Scholar
• Perella D, Wang C, Civen R. Varicella vaccine effectiveness in preventing community transmission in the 2-dose era. Pediatrics. 2016;137(4):e20152802.
   Web of Science ®Google Scholar
• Cenoz MG, Martinez AV, Guevara M, Ezpeleta C, Barricarte A, Castilla J. Effectiveness of one and two doses of varicella vaccine in preventing laboratory-confirmed cases in children in Navarre Spain. Hum Vaccin Immunother. 2013;9(5):1172–76. doi:10.4161/hv.23451.
   PubMed Web of Science ®Google Scholar
• Siedler A, Rieck T, Tolksdorf K. Strong additional effect of a second varicella vaccine dose in children in Germany, 2009-2014. J Pediatr. 2016;173:202–206.e2. doi:10.1016/j.jpeds.2016.02.040.
   PubMed Web of Science ®Google Scholar
• Yin M, Xu X, Liang Y, Ni J. Effectiveness, immunogenicity and safety of one vs. two-dose varicella vaccination: a meta-analysis. Expert Rev Vaccines. 2018;17(4):351–62. doi:10.1080/14760584.2018.1433999.
   PubMed Web of Science ®Google Scholar
• Zhu S, Zeng F, Xia L. Incidence rate of breakthrough varicella observed in healthy children after 1 or 2 doses of varicella vaccine: results from a meta-analysis. Am J Infect Control. 2018;46(1):e1–e7. doi:10.1016/j.ajic.2017.07.029.
   PubMed Web of Science ®Google Scholar
• Wutzler P, Bonanni P, Burgess M, Gershon A, Sáfadi MA, Casabona G. Varicella vaccination-The global experience. Expert Rev Vaccines. 2017;16(8):833–43. doi:10.1080/14760584.2017.1343669.
   PubMed Web of Science ®Google Scholar
• Spackova M, Wiese PM, Dehnert M, Matysiak-Klose D, Heininger U, Siedler A. Comparative varicella vaccine effectiveness during outbreaks in daycare centres. Vaccine. 2010;28(3):686–91. doi:10.1016/j.vaccine.2009.10.086.
   PubMed Web of Science ®Google Scholar